Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the German COSYCONET cohort.

F. Trudzinski (Homburg, Germany), K. Kahnert (Munich , Germany), C. Vogelmeier (Marburg , Germany), P. Alter (Marburg , Germany), F. Seiler (Homburg , Germany), S. Fähndrich (Freiburg , Germany), H. Watz (Grosshansdorf , Germany), T. Welte (Hannover , Germany), T. Speer (Homburg , Germany), S. Zewinger (Homburg , Germany), F. Biertz (Hannover , Germany), H. Kauczor (Heidelberg , Germany), R. Jörres (Munich , Germany), R. Bals (Homburg , Germany)

Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Session: Lung function evaluation and prognosis of airway diseases
Session type: Oral Presentation
Number: 510
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Trudzinski (Homburg, Germany), K. Kahnert (Munich , Germany), C. Vogelmeier (Marburg , Germany), P. Alter (Marburg , Germany), F. Seiler (Homburg , Germany), S. Fähndrich (Freiburg , Germany), H. Watz (Grosshansdorf , Germany), T. Welte (Hannover , Germany), T. Speer (Homburg , Germany), S. Zewinger (Homburg , Germany), F. Biertz (Hannover , Germany), H. Kauczor (Heidelberg , Germany), R. Jörres (Munich , Germany), R. Bals (Homburg , Germany). Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the German COSYCONET cohort.. 510

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Influences of lung and left heart function on respiratory symptoms in COPD: Results from the COSYCONET cohort
Source: International Congress 2019 – New insights into respiratory function testing
Year: 2019




Relationship of hyperlipidemia to comorbidities and lung function in COPD: results of the COSYCONET cohort
Source: International Congress 2017 – COPD: risk factors and prognosis
Year: 2017

The effects of bronchodilators on regional lung sound distribution in patients with COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013

Mometasone/indacaterol/glycopyrronium (MF/IND/GLY) improves lung function and reduces exacerbations in patients with asthma, independent of baseline airflow limitation: Results from IRIDIUM study
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021


LVRS improves endothelial function and blood pressure in patients with COPD: A randomized-controlled trial
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015


Chronic lung allograft disease: prevalence and FEV1 decline in a Brazilian lung transplant cohort.
Source: International Congress 2017 – Lung transplant outcomes
Year: 2017


The impact of underlying disease on baseline pulmonary function values after lung transplantation
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016


Indacaterol/glycopyrronium (IND/GLY) improves lung function irrespective of gender baseline differences in patients with COPD: A pooled analysis from the IGNITE Program
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016

The influence of smoking on capnometry lung ventilation parameters in chronic obstructive pulmonary disease patients
Source: International Congress 2015 – Molecular pathways of lung injury due to tobacco-related products
Year: 2015


Airway responsiveness predicts lung function decline differently in subjects with or without asthma: An international study
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013

The presence and impact of chronic kidney disease in COPD patients, data from the German COSYCONET cohort
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017

Effects of lifetime smoking patterns on nutrition, muscular and lung function in early COPD patients from the PAC-COPD cohort study
Source: Eur Respir J 2007; 30: Suppl. 51, 283s
Year: 2007

Predictors of lung function deterioration in COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


The association between lung function and exacerbation frequency in patients with COPD, results from a systemic review
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009

Estimating lung function decline and the effect of smoking in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 578s
Year: 2002

Respiratory function and the risk of lung cancer in COPD patients: A population-based cohort study
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016

Estimated postoperative pulmonary function and 6 months recovery for lobectomized lung cancer patients with and without COPD
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016

Detecting specific clusters of asthma and COPD patients using fluctuation based clustering of daily lung function recordings in the BIOAIR study
Source: International Congress 2015 – Any news from the asthma field?
Year: 2015


Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005


Bacterial infection in hospitalized patients of acute exacerbation of COPD and their relation to lung function: A prospective study
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016